Centene reported strong third-quarter results with revenue of $32.4 billion, an 11% increase year-over-year, and adjusted earnings per share of $1.26. Its health benefits ratio was 88.1%. Centene has reorganized its business to focus on margin expansion through various initiatives, including SG&A efficiencies, medical management, and portfolio optimization. Despite the pandemic, its Medicaid membership increased to 14.8 million, and it expanded its Medicare footprint to reach 48 million eligible adults. Looking ahead, Centene expects modest adjusted earnings per share growth in 2022 and remains committed to achieving an investment grade rating and a disciplined capital allocation framework. It is confident in its value creation plan and anticipates greater impact towards its financial goals over the next few years.